Is microsatellite instability-high really a favorable prognostic factor for advanced colorectal cancer? A meta-analysis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Is microsatellite instability-high really a favorable prognostic factor for advanced colorectal cancer? A meta-analysis
Authors
Keywords
-
Journal
World Journal of Surgical Oncology
Volume 17, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-10-22
DOI
10.1186/s12957-019-1706-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part II—The Challenge of Programmed Death Ligand-1 Testing and Its Role in Microsatellite Instability-High Colorectal Cancer
- (2018) Esmeralda Celia Marginean et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part I—Colorectal Cancer: Microsatellite Instability, Testing, and Clinical Implications
- (2018) Esmeralda Celia Marginean et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
- (2018) Franck Pagès et al. LANCET
- Prognostic significance of BRAF mutation alone and in combination with microsatellite instability in stage III colon cancer
- (2018) Hanumant Chouhan et al. Asia-Pacific Journal of Clinical Oncology
- Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology
- (2017) Al B. Benson et al. Journal of the National Comprehensive Cancer Network
- Systematic immunohistochemical screening for mismatch repair and ERCC1 gene expression from colorectal cancers in China: Clinicopathological characteristics and effects on survival
- (2017) Pan Li et al. PLoS One
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Microsatellite Instability was not Associated with Survival in Stage III Colon Cancer Treated with Adjuvant Chemotherapy of Oxaliplatin and Infusional 5-Fluorouracil and Leucovorin (FOLFOX)
- (2016) Jeong Eun Kim et al. ANNALS OF SURGICAL ONCOLOGY
- Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers
- (2016) Chang Gon Kim et al. BRITISH JOURNAL OF CANCER
- Prognostic and predictive value of extendedRASmutation and mismatch repair status in stage III colorectal cancer
- (2016) Yusuke Sasaki et al. CANCER SCIENCE
- Microsatellite instability is associated with reduced disease specific survival in stage III colon cancer
- (2016) H.M. Mohan et al. EJSO
- PD-L1 expression in colorectal cancer is associated with microsatellite instability, BRAF mutation, medullary morphology and cytotoxic tumor-infiltrating lymphocytes
- (2016) Matthew W Rosenbaum et al. MODERN PATHOLOGY
- Prognostic Effect ofBRAFandKRASMutations in Patients With Stage III Colon Cancer Treated With Leucovorin, Fluorouracil, and Oxaliplatin With or Without Cetuximab
- (2016) Julien Taieb et al. JAMA Oncology
- Mismatch repair status and synchronous metastases in colorectal cancer: A nationwide cohort study
- (2015) Andreas Nordholm-Carstensen et al. INTERNATIONAL JOURNAL OF CANCER
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association between mismatch repair gene and irinotecan-based chemotherapy in metastatic colon cancer
- (2015) Junli Ma et al. TUMOR BIOLOGY
- Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trial
- (2014) D. Klingbiel et al. ANNALS OF ONCOLOGY
- Mismatch Repair Status and BRAF Mutation Status in Metastatic Colorectal Cancer Patients: A Pooled Analysis of the CAIRO, CAIRO2, COIN, and FOCUS Studies
- (2014) S. Venderbosch et al. CLINICAL CANCER RESEARCH
- Ephrin B2 Receptor and Microsatellite Status in Lymph Node-Positive Colon Cancer Survival
- (2014) Arik Drucker et al. Translational Oncology
- Prognostic value of microsatellite instability and p53 expression in metastatic colorectal cancer treated with oxaliplatin and fluoropyrimidine-based chemotherapy
- (2014) S. Nöpel-Dünnebacke et al. ZEITSCHRIFT FUR GASTROENTEROLOGIE
- The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints
- (2014) Nicolas J. Llosa et al. Cancer Discovery
- Prognostic Value of Mucinous Histology Depends on Microsatellite Instability Status in Patients with Stage III Colon Cancer Treated with Adjuvant FOLFOX Chemotherapy: A Retrospective Cohort Study
- (2013) Se Hyun Kim et al. ANNALS OF SURGICAL ONCOLOGY
- Prognostic Impact of Deficient DNA Mismatch Repair in Patients With Stage III Colon Cancer From a Randomized Trial of FOLFOX-Based Adjuvant Chemotherapy
- (2013) Frank A. Sinicrope et al. JOURNAL OF CLINICAL ONCOLOGY
- Oncologic Outcomes after Adjuvant Chemotherapy Using FOLFOX in MSI-H Sporadic Stage III Colon Cancer
- (2013) Seung Yeop Oh et al. WORLD JOURNAL OF SURGERY
- Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer
- (2011) Ben Tran et al. CANCER
- Association between deficient mismatch repair system and efficacy to irinotecan-containing chemotherapy in metastatic colon cancer
- (2011) Jeong Eun Kim et al. CANCER SCIENCE
- Defective Mismatch Repair Status as a Prognostic Biomarker of Disease-Free Survival in Stage III Colon Cancer Patients Treated with Adjuvant FOLFOX Chemotherapy
- (2011) A. Zaanan et al. CLINICAL CANCER RESEARCH
- DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy
- (2011) F. A. Sinicrope et al. JNCI-Journal of the National Cancer Institute
- Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer
- (2010) Daniel J. Sargent et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of p53 expression and microsatellite instability on stage III colon cancer disease-free survival in patients treated by 5-fluorouracil and leucovorin with or without oxaliplatin
- (2009) A. Zaanan et al. ANNALS OF ONCOLOGY
- Microsatellite Instability Predicts Improved Response to Adjuvant Therapy With Irinotecan, Fluorouracil, and Leucovorin in Stage III Colon Cancer: Cancer and Leukemia Group B Protocol 89803
- (2009) Monica M. Bertagnolli et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now